Salmon lice drug secures new funding

Jan Rune Nordhagen

Source: Thor Brødreskift

Sarsia and Coast Seafood inject NOK 12 million into Norwegian biotech company Vestland Pharma

Norwegian biotech company Vestland Pharma, which has patented a drug against salmon lice, has received fresh backing, with venture company Sarsia and the seafood company Coast Seafood becoming shareholders.

Continue this article…

Already subscribed? SIGN IN now

WF Digital

Register for a FREE one-month trial to continue this article

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:

  • Weekly newsletters providing valuable news and information on the commercial fishing and aquaculture sector
  • Full access to our news archive
  • Live and archived webinars, podcasts and videos
  • Articles on innovations and current trends in the commercial fishing industry
  • Our extensive archive of data, research and intelligence

Get more free content sign up today

Ready to subscribe? Choose from one of our subscription packages for unlimited access!